Почетна › Akutna mijeloidna leukemija › Њу Џерзи

Kliničke studije za Akutna mijeloidna leukemija u državi Њу Џерзи

31 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u državi Њу Џерзи.

Gradovi u državi Њу Џерзи

Zvanični tekst studije (na engleskom)

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooperman Barnabas Medical Center, Livingston
Monmouth Medical Center, Long Branch
и још 6

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06317649

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Rutgers Biomedical and Health Sciences, New Brunswick

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

A Study of CRD3874-SI in People With Leukemia

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07661095

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooper Hospital University Medical Center, Camden
Cooperman Barnabas Medical Center, Livingston
и још 7

Тражи се учесникФаза 2

Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Englewood Hospital and Medical Center, Englewood
Hackettstown Medical Center, Hackettstown
Morristown Medical Center, Morristown
и још 7

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле

Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06852222

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
и још 1

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06484062

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooper Hospital University Medical Center, Camden
Cooperman Barnabas Medical Center, Livingston
и још 7

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooperman Barnabas Medical Center, Livingston
Monmouth Medical Center, Long Branch
и још 6

Тражи се учесникФаза 2

Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooperman Barnabas Medical Center, Livingston
Monmouth Medical Center, Long Branch
и још 4

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06672146

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

Clinical Trial Site, Morristown

Тражи се учесникФаза 3

Узраст 12 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07211958

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Тражи се учесникФаза 1/2

Узраст 12 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07356154

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

John Theurer Cancer Center / Hackensack University, Hackensack

Тражи се учесникФаза 2/3

Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04256317

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Тражи се учесникФаза 1

Узраст 1 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06017258

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Тражи се учесникФаза 2

Узраст 60 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07392242

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Тражи се учесникФаза 1

Узраст од 12 до 78 · Оба пола · Ажурирано 29. 9. 2026. · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Jersey Shore Medical Center, Neptune City
и још 4

Тражи се учесникФаза 3

6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

John Theurer Cancer Center at Hackensack UMC, Hackensack

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT06824168

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Atlantic Health, Morristown

Тражи се учесникФаза 1/2

Узраст 12 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Jersey Shore Medical Center, Neptune City
и још 3

Тражи се учесникФаза 1/2

До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT06001788

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

MDA at Cooper University Health Care, Camden

Тражи се учесникРана фаза 1

Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07771803

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Atlantic Health, Morristown

Тражи се учесникФаза 2/3

Узраст од 18 до 80 · Оба пола · Ажурирано 5. 8. 2026. · NCT06788756

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hackensack University Medical Center, Hackensack
Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick

Тражи се учесникОпсервациона студија

Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Тражи се учесникФаза 1

Узраст од 18 до 70 · Оба пола · Ажурирано 17. 6. 2026. · NCT07011004

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Atlantic Health, Morristown
Rutgers Cancer Institute of New Jersey, New Brunswick

Тражи се учесникФаза 1/2

Узраст 12 и старији · Оба пола · Ажурирано 24. 3. 2026. · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 23. 3. 2026. · NCT04990102

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Hackensack University Medical Center, Hackensack
Rutgers Cancer Institute, New Brunswick

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 13. 3. 2026. · NCT05735184

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 10. 3. 2026. · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 24. 2. 2026. · NCT06773208

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.